Clinical Trials Directory

Trials / Completed

CompletedNCT00981071

The Time of Positive Conversion of Interferon-γ Releasing Assay After Tuberculosis Exposure

Status
Completed
Phase
Study type
Observational
Enrollment
32 (actual)
Sponsor
Armed Forces Capital Hospital, Republic of Korea · Other Government
Sex
Male
Age
Healthy volunteers
Accepted

Summary

The aim is to evaluate the time of positive conversion after exposure to smear positive pulmonary tuberculosis (TB) in a platoon of Korean military, a closed communal setting.

Detailed description

In a platoon where TB outbreak occurred, we performed low dose chest CT (LDCT), QuantiFERON-TB gold in tube (QFT) and two-step (0, 4weeks) TST for outbreak investigation. We perform QFT at 0, 2, 4, 8 and 12 weeks after initial investigation for soldiers with negative QFT results, and soldiers with positive QFT and normal LDCT took isoniazid and rifampin for 3 months as treatment of latent TB.

Conditions

Timeline

Start date
2009-05-01
Primary completion
2010-04-01
Completion
2010-04-01
First posted
2009-09-22
Last updated
2010-04-08

Source: ClinicalTrials.gov record NCT00981071. Inclusion in this directory is not an endorsement.

The Time of Positive Conversion of Interferon-γ Releasing Assay After Tuberculosis Exposure (NCT00981071) · Clinical Trials Directory